Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.95 CHF | +0.12% | -0.61% | +15.72% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
Sales 2024 * | 182M 200M | Sales 2025 * | 206M 226M | Capitalization | 491M 539M |
---|---|---|---|---|---|
Net income 2024 * | 23M 25.26M | Net income 2025 * | 35M 38.43M | EV / Sales 2024 * | 3.02 x |
Net Debt 2024 * | 57.88M 63.56M | Net Debt 2025 * | 12.51M 13.73M | EV / Sales 2025 * | 2.45 x |
P/E ratio 2024 * |
20.5
x | P/E ratio 2025 * |
17.3
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.55% |
Latest transcript on Basilea Pharmaceutica AG
1 day | +0.12% | ||
1 week | -0.61% | ||
Current month | +8.50% | ||
1 month | +10.70% | ||
3 months | +20.86% | ||
6 months | +10.41% | ||
Current year | +15.72% |
Managers | Title | Age | Since |
---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 59 | 14-08-31 |
Adesh Kaul
DFI | Director of Finance/CFO | 50 | 08-12-31 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 60 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nicole Onetto
BRD | Director/Board Member | 71 | 17-04-26 |
Leonard Kruimer
BRD | Director/Board Member | 66 | 21-12-31 |
Director/Board Member | 69 | 13-04-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +1.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 40.75 | -0.37% | 14 066 |
24-04-22 | 40.9 | +0.37% | 37,920 |
24-04-19 | 40.75 | -2.86% | 38,782 |
24-04-18 | 41.95 | +0.60% | 37,123 |
24-04-17 | 41.7 | +1.46% | 28,574 |
Delayed Quote Swiss Exchange, April 23, 2024 at 04:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.72% | 538M | |
-0.02% | 42.11B | |
+46.28% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- BSLN Stock